Paris, France 7/16/18—Eurobio Scientific, a publicly held French company that supplies diagnostic and life science products, has purchased Dendritics for an undisclosed amount. Dendritics develops, manufactures and sells antibodies, specializing in antibodies targeting immune system cells. In 2017, Dendritics generated revenues of €350,000 ($393,258 at €0.89 = $1). “This merger allows Eurobio Scientific to strengthen its production activities by offering custom antibody manufacturing services as well as an extensive portfolio of proprietary monoclonal antibodies,” stated Jean-Michel Carle, chairman of Eurobio Scientific’s Management Board.  “By using the innovative technology of Dendritics, we will also be able to develop new proprietary products, particularly in the field of diagnostics.”,

Eurobio Scientific offers and is developing diagnostic tests for for immunology and infectious diseases, as well as the FDA-approved Allomap gene expression test for heart transplantation recipients.  In the first half of 2018, its revenues, including Dendritics, rose 28.1% to €25.1 million ($30.2 million at €0.83 = $1). 

The purchase expands the company’s offering by adding antibody manufacturing capabilities, as well as a catalog of antibody products that can be used both to develop new tests and for direct sale.